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Summary. The duplication of genes for recognition 
molecules and the ensuing diversification of the 
members of such families generate complex groups of 
homologous proteins. One example are galactoside- 
specific lectins whose sequences display constant 
features related to sugar binding, the galectins. Based on 
the inverse abundance of the chicken galectins CG-14 
and CG-16 in adult intestine and liver, these two lectins 
represent a model to comparatively study expression of 
the related proteins and the galectin-reactive sites 
(glycoproteins and glycolipids) biochemically and 
histochemically. Functional overlap andtor acquisition of 
distinct functions would be reflected in qualitative 
andlor quantitative aspects of ligand display. Using five 
different stages of embryogenesis, differential regulation 
of the two galectins was detected in liver and intestine. 
The clear preference for one galectin (CC-14) was 
observed in intestine already at rather early stages, 
whereas equivalence for both proteins was noted in liver 
from day 12 to day 18 prior to hatching, as seen by 
ELISA assays and Western blot analysis. Presentation of 
galectin-reactive glycoproteins showed a tendency for 
gradual increase in both organs. Galectin-blotting 
analysis revealed primarily very similar patterns of 
positive bands at the different stages of development and 
only few quantitative and qualitative changes. The 
reactivity of glycolipids in a solid-phase assay was more 
variable, even surpassing the response of extracts of the 
adult organ at several embryonic stages. While the 
localization patterns of the galectins and galectin- 
reactive sites were nearly indistinguishable in the liver, 
intestinal tissue differed with respect to the placement 
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and accessibility of binding sites. Thus, the results 
suggest a differential regulation of galectin activities in 
the two organs. As a sum they resemble the course of 
development of availability of glycoprotein ligands in 
vitro. These findings support the notion for a partial 
functional redundancy in this family. The described 
approach to employ galectin-specific antibodies and the 
labeled galectins as tools to assess presentation of 
ligands is suggested to be of general relevance to address 
the question of distinct vs. overlapping functions of 
related recognition molecules. 
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Introduction 
Starting with the duplication of an ancestral gene, 
the ensuing diversification can produce an array of 
related proteins. Ideally, they can acquire special 
properties in the course of this process which are tailored 
to fulfil1 distinct functions. Under these circumstances, it 
is readily apparent that a separation into partially 
redundant activities will confer a selective advantage 
with evolutionary stability (Thomas, 1993). This process 
entails the requirement for devising control mechanisms 
to accurately tune on gene expression of the specialized 
products in response to the demand. Although proteins 
are definitely precious commodities, cells may tolerate 
to continue to synthesize a member of a gene family, if 
the expenses for providing an accurate organ-specific 
control mechanism surpass that of producing an 
innocuous protein (Erickson, 1993). We are thus faced 
with the problems to define the overlap of biological 
significance and to distinguish truly functional from 
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evidently superfluous expression in the different organs. 
To clarify these issues, it is a reasonable starting point to 
precisely monitor the expression of the different receptor 
proteins in different organs. When they exert their 
functions by recognitive processes, the next step is the 
quantitative assessment of the presence of ligands to 
reveal any measurable adaptation between a certain 
receptor and its binding partners. These two questions 
will be addressed for a model of two homologous 
receptor proteins in the development of two chicken 
organs. 
Owing to their placement in the non-reducing 
terminal section of glycan chains galactosides are 
spatially accessible docking points for sugar receptors. 
Glycosylation imparts glycoproteins the ability to be 
engaged in recognitive interactions on the basis of the 
sugar code for biological information (for a collection of 
recent reviews illuminating the field, see Gabius and 
Gabius, 1997; Gabius and Sinowatz, 1998). Indeed, this 
assumed function has actually been verified in the 
interplay with C-type lectins and galectins. The members 
of the latter family of animal lectins share a conserved 
motif for the carbohydrate recognition domain, which is 
the basis for their classification (Kasai and Hirabayashi, 
1996; Gabius, 1997a; Hirabayashi, 1997; Kaltner and 
Stierstorfer, 1998). Following the initial descriptions of a 
chicken galectin (CG-16) activity, its developmental 
regulation and biochemical characteristics were 
determined (Nowak et al., 1976, 1977;  Den and 
Malinzak, 1977; Kobiler and Barondes, 1977; Eisenbarth 
et al., 1978; Kobiler et al., 1978; Beyer et al., 1979; 
Cook et al., 1979; Yamagata and Nishiwaki, 1979). 
Systematic studies were pertinent to assess whether the 
capacity for galectin expression was confined to this 
protein. In the course of this work a second activity was 
subsequently purified, termed CG-14 on the basis of its 
monomer molecular weight (Beyer et al., 1980). Relative 
to CG-16 it has a rather weak activity for hemagglutina- 
tion, what is explained by a more pronounced tendency 
to be present as monomer in the native state relative to 
CG-16 (Beyer et al., 1980; Hirabayashi et al., 1987; 
Kakita et al., 1991; Castagna and Landa, 1994; Schneller 
et al., 1995). Remarkably, initial measurements of the 
developmental regulation indicated independent control 
mechanisms to be operative for the two galectins (Beyer 
and Barondes, 1982a; Levi and Teichberg, 1989; 
Akimoto et al., 1993, 1995; Guay and Zalik, 1994). 
Since the time of origin of the two genes after 
duplication of the ancestral genetic coding unit had been 
assigned to a period close to the divergence of birds and 
mammals approximately 3 X 10* years ago (Sakakura et 
al., 1990), the length of the subsequent period clearly 
should have been sufficient to enable the galectins to 
acquire distinct features. As an indicator for disparate 
properties the mapping of the combining sites with 
engineered ligands had recently unraveled differences in 
their architecture (Solis et al., 1996). Since neither the 
extent of ligand presentation for the two galectins nor 
the developmental regulation of galectin-reactive sites 
are known, we addressed these questions by biochemical 
and histochemical studies at various stages of 
development pre and post hatching for two organs with 
widely different abundance for the two galectins in adult 
chicken. These investigations were rendered feasible by 
purification of the endogenous lectins, their labeling 
under activity-preserving conditions and their 
introduction as analytical tools for systematic ligand 
monitoring, as exemplarily documented previously for 
mammalian galectin-l and heparin-binding lectin 
(Gabius et al., 1991a,b, 1993; Joubert-Caron, 1993). 
Since apparently differential regulation has also been 
inferred for mammalian galectins in normal and 
transformed cells (Cerra et al., 1985; Gabius et al., 
1986a,b; Fowlis et al., 1995; Xu et al., 1995; Colnot et 
al., 1996, 1997; Gillenwater et al., 1996; Gabius, 1997b; 
Ohannesian and Lotan, 1997; van den Brule et al., 1997) 
the results of this study can have relevance beyond avian 
development. 
Materials and methods 
Lectin isolation, antibody preparation and probe labeling 
Following tissue extraction (liver and intestine) with 
75 mM phosphate-buffered saline (pH 7.2) containing 4 
mM f3-mercaptoethanol, 2 mM EDTA, 0 .1  mM 
benzylsulfonyl fluoride and 0.1M lactose, centrifugation 
and dialysis of the supernatant to remove lactose, the 
chicken galectins were purified by successive steps of 
affinity chromatography on lactosylated Sepharose 4B, 
obtained after divinyl sulfone activation, and anion- 
exchange chromatography on a Mono Q column (1 ml 
resin; Pharmacia, Freiburg, FRG), as  described 
previously (Gabius, 1990; Schneller et al., 1995). To 
stabilize their activities which are sensitive to oxidation 
of sulfhydryl groups, carboxyamidomethylation of the 
galectins was routinely carried out with 50 mM iodo- 
acetamide during elution in the first chromatographic 
step. The galactoside-specific lectin from mistletoe 
(Viscum album agglutinin, VAA) was purified by affinity 
chromatography, as  described by Gabius (1990). 
Analysis of lectin purity by one- and two-dimensional 
gel electrophoresis, silver staining of gels, determination 
of protein concentration and of lectin activity by 
hemagglutination was performed, as described in detail 
previously (Gabius et al., 1984; Schneller et al., 1995). 
Polyclonal antibodies against the chicken galectins were 
raised in rabbits, the lack of cross-reactivity was 
ascertained by solid-phase assays in microplates and by 
Western blotting and affinity purification on lectin- 
containing Affi-gel 10115 (3 mgtml; Bio-Rad, Munich, 
FRG) was performed, as described (Bardosi et al., 1989; 
Zeng and Gabius, 1991). The purified fractions of 
antibodies which were free of cross-reactive activity 
were labeled by covalent conjugation with periodate- 
treated horseradish peroxidase (Nakane and Kawaoi, 
1974). Chemical modification with biotinyl-N-hydroxy- 
succinimide ester (Sigma, Munich, FRG) under mild, 
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activity-preserving conditions yielded labeled lectins, 
which were routinely checked for the integrity of the 
activity and of the native molecular weight after label 
introduction and after storage to exclude fractions with 
aberrant properties (Gabius et al., 1991a; Kaltner et al., 
1997). 
Quantitation of galectins and of galectin-reactive 
glycoproteins in tissue extracts 
Fertilized eggs were incubated at 37 "C and 63-67% 
humidity for distinct periods of time. Tissue samples of 
liver and intestine were collected at defined stages of 
embryogenesis. Following extractions of the specimen in 
detergent-free and in 1% Triton X-100 and 0.1 % sodium 
deoxycholate-containing buffers to which 0.1M lactose 
was added to reduce binding of soluble galectin to 
insoluble cell material, a sandwich ELISA assay in 
microtiter plates (Greiner, Niirtingen, FRG) was 
performed using affinity-purified antibody fractions in 
the first step (0.5 pg/ml) and the peroxidase-labeled 
fractions in the detection step (5 pg/ml), as described by 
Kaltner et al. (1997). Using calibration curves with the 
purified galectins, the quantity of lectin present in each 
extract sample was determined routinely in the linear 
range of the calibration curve, the detection limit being 
approximately 2-2.5 ngtml. In order to similarly 
quantitate the amount of galectin-reactive glyco- 
conjugates in a solid-phase assay, a constant quantity of 
extract protein (2.5 pg)  was exposed to the surface of 
microtiter plate wells for adsorption over 12 h at 37 "C. 
Further assay steps including blocking, washing, probing 
with biotinylated lectin, washing, further probing with 
streptavidintperoxidase conjugate (0.5 pglml; Sigma, 
Munich, FRG), washing and addition of the chromo- 
genic substrates o-phenylenediamine (1mg/ml)/H202 
(0.004%; vtv) were carried out, as described previously 
(Gabius et al., 1991a; Kaltner et al., 1997). The level of 
carbohydrate-dependent binding was assessed by assays, 
in which each biotinylated lectin, which had been 
preincubated with a solution containing 5 0  p g  
asialofetuintml and 50pM lactose to saturate the binding 
sites, and the noted potent glycoinhibitors were present 
to preclude any interaction between glycoproteins on the 
surface of the plate wells and the agglutinins by protein- 
carbohydrate interaction. The OD-values of the assays 
are expressed as ng asialofetuin based on standard 
curves with this model glycoprotein. 
Visualization of galectins and galectin-reactive 
glycoproteins on blots 
Aliquots of tissue extracts with constant quantities of 
either 20 p g  proteintlane for Western blot analysis after 
one extraction step with detergent-containing buffer or 5 
pgllane after fractionated extraction for lectin-binding 
analysis of lectin-reactive glycoproteins were subjected 
to electrophoresis under denaturing and reductive 
conditions either on a 15 % polyacrylamide gel (Western 
blotting) or a 12% polyacrylamide gel (lectin blotting). 
The proteins were thereafter transferred by tank blotting 
to nitrocellulose (Schleicher und Schuell, Dassel, FRG; 
0.2 pm). Probing was performed either with affinity- 
purified immunoglobulin G fractions or biotinylated 
lectins in conjunction with commercial peroxidase- 
labeled goat anti-rabbit immunoglobulin G or  a 
streptavidintalkaline phosphatase conjugate, as described 
previously (Gabius et al., 1986b, 1991a; Kaltner et al., 
1997). Addition of a mixture of 0.3M lactose and 0.25 
mg asialofetuintml was employed to determine 
carbohydrate-independent binding, and addition of an 
excess of galectin to the antibody-containing solution to 
exclude antigen-independent binding. The incubation 
steps with primary antibody or labeled lectin were 
deliberately omitted in independent experiments to 
visualize staining, for which indicator reagents (second 
antibody, kit components) are responsible. 
Quantitation of galectin-binding neutral glycolipids and 
gangliosides in tissue extracts 
Tissue samples of embryonic and adult chicken liver 
or intestine (approximately 1 g wet weight) were 
homogenized in 4 m1 chloroform/methanol (2:l; v/v), as 
described previously (Kaltner et al., 1997). Following 
centrifugation each supernatant was passed over a 
Sephadex A-25 column (bed volume: 18 ml; Pharmacia, 
Freiburg, FRG) to fractionate neutral glycolipids, 
obtained by a washing step with 50 m1 chloroform/ 
methanoltwater (40:60:8, by volume), and gangliosides, 
obtained by subsequent elution with chloroform/ 
methanol/0.8M sodium acetate (40:60:8, by volume). 
After cautious evaporation of the solvent below 40 "C 
waterbath temperature each sample of dried glycolipid 
was thoroughly resuspended in 5 m1 methanol and 
aliquots of this solution diluted with methanol were used 
to coat the surface of the microtiter plate wells with 
glycolipids over a period of 2 h at 37  "C. Further 
processing has been described in detail elsewhere 
(Kaltner et al., 1997). The  concentrations of the 
biotinylated lectins had to be adjusted to different values 
to maintain a constant ligand display in the assay, i.e. 0.1 
p g  mistletoe lectint100 pl,  0.2 p g  CG-14/100 p1 and 5 
p g  CG-16/100 p l .  Each ser ies  of triplicates was 
accompanied by the assessment of the extent of sugar- 
inhibitable binding and the background values due to the 
interaction of kit reagents with the matrix. Purified 
lactosylceramide and ganglioside GMI were also tested. 
For comparison between the individual samples the OD- 
values for carbohydrate-mediated binding were 
normalized to 1 mg wet weight of each tissue sample. 
Visualization of lectin-reactive sites and of the galectins 
in tissue sections 
Fresh tissue specimens were immediately fixed in 
Bouin's solution or 4% buffered paraformaldehyde. In 
addition to the different time points of embryogenesis, 
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explicitly given in Table 1, livers and intestines were 
removed from adult chicken and from chicken 1, 2, 3 or 
6 weeks post hatching. Further processing of the samples 
by embedding in paraffin, preparation of 5 pm sections 
and probing with biotinylated lectins at a concentration 
of 1 pglml or with galectin-specific immunoglobulin G 
fractions at a concentration of 2 pg/ml overnight at 4 "C 
followed the optimized protocol (Kaltner et al., 1997). 
Control reactions included preadsorption of the antibody 
preparations with an excess of corresponding galectin, 
deliberate omission of the incubation step with the probe 
(biotinylated lectins or antibodies) and inhibition of 
sugar-dependent binding by coincubation of the lectins 
with 0.1M lactose (mistletoe agglutinin) or with a 
mixture of 0.2M lactose and 0.65 mg asialofetuin/ml 
(galectins). 
Statistical analysis 
Based on the commercial Sigma Stat 1.0 package 
(Jandel Scientific, Erkrath, Germany) the one-way 
analysis of variance on ranks, Dunn's multiple 
comparison test for calculation of significance of sets of 
values and the Mann-Whitney rank sum test were used. 
Results 
To monitor galectin expression in the course of 
development, antibody fractions are convenient tools. 
Due to the expression of two galectins in chicken liver 
and intestine contamination of a preparation by the less 
abundant protein can be the source for undesirable cross- 
reactivity of antibody fractions. Following affinity 
chromatography anion-exchange chromatography was 
crucial to completely weed out minor traces of the other 
galectin owing to the difference in isoelectric points 
between CG-14 and CG-16 of more than two units 
(Schneller et al., 1995). Using preparations which were 
free of any contamination according to silver staining 
after slab gel electrophoresis as starting material for 
immunization, polyclonal immunoglobulin G fractions 
against the two galectins were raised in rabbits. Their 
analysis by solid-phase assays in microtiter plates and on 
nitrocellulose ascertained that these fractions were 
specific for the galectin, which had been employed as 
antigen, as shown for a Western blot in Fig. 1. Having 
gained access to the required monospecific probes 
technical details of the methods could be addressed. To 
exclude an assay-inherent bias two independent methods 
were used to determine the expression of the two 
galectins in the course of development, i.e. blotting 
analysis and a sandwich ELISA technique. Its detection 
limit was approximately 2-2.5 ng galectinlml and the 
recovery ratio of each galectin, which had been added to 
extracts in known quantities, was consistently above 
85%. To exclude masking of galectins by association to 
insoluble material, 0.1M lactose was added to the 
detergent-containing extraction buffer. Moreover, 
treatment of the residual pellets with the standard sample 
buffer for gel  electrophoresis under denaturing 
conditions and boiling rendered no measurable amount 
of galectin assessible to the analytical tools. To rule out a 
lack of immunodetection of ligand-bound galectins in 
the supernatants, this situation was simulated with 
asialofetuin as model ligand, revealing unimpaired 
concentration-dependent signal development. Having 
thus documented the validity of the reagents and assay 
conditions, the questions could be addressed as to what 
extent the expression of the two galectins is 
developmentally regulated and whether the course of 
regulation is different in liver and intestine, which harbor 
a predominant type of galectin at the adult stage. 
While Table 1 presents the summary of the 
individual data sets of the sandwich ELISA assay, an 
exemplary documentation of the course of galectin 
expression for a single case per time point as monitored 
by Western blotting is presented in Figs. 2, 3. The 
contents of the two galectins in liver remained rather 
constant from day 1 2  of embryogenesis and the 
preference for CG-16 was established after hatching, 
CG-14 only reaching a relative amount of below 20% of 
CG-16 (Table 1 ,  Fig. 2).  The course of galectin 
expression was significantly different in intestine. 
Evidently, the relative abundance of the two galectins 
was not kept constant in the two types of organ. An 
obvious preference of CG-14 expression in the intestine 
was apparent even at early stages of embryogenesis 
(Table 1, Fig. 3). Whereas the CG-16 content remained 
nearly unchanged during embryogenesis from day 10 to 
day 18  and further dropped for the adult stage, the 
expression level of CG-14, which already surpassed that 
of CG-16 at day 10, continuously increased and 
dominated by far at the adult stage (Table 1, Fig. 3). It is 
thus suggestive to assume a preferential role of CG-14 in 
Flg. 1. Analysis of 
16 and CG-14 are 
and the proteins are 
electroblotted onto 
a b c  purified polyclonal IgG against CG-16 (a), 
affinity-purified polyclonal IgG against CG-14 (b) or a mixture of both 
antibody fractions (c), respectively, are used. 
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intestine from late stages of pre-hatching maturation 
onwards and at the adult stage. Having addressed the 
question of regulation of two galectins in development 
of liver and intestine, it is imperative to determine 
whether the ligand availability is  a lso subject to 
developmental regulation. It may be controlled by 
completely different regulatory constraints in 
development. It may, too, be dissimilar with respect to 
the two proteins owing to fine-specificity differences of 
the galectins for carbohydrate ligands. The monitoring of 
ligand sites was exclusively based on carbohydrate 
recognition, using OD-values of the solid-phase assay 
and the staining profile of lectin blots only after 
adequate controls to prove inhibition by glycoinhibitors. 
Two independent methods were applied to assess the 
total amount of accessible glycoprotein ligands in 
extracts and the profile of glycoproteins which are 
reactive in lectin blots. 
Prior to the presentation of the results of the 
microtiter plate assay for lectin-reactive glycoproteins a 
Table l. Determination of the CG-14 and CG-16 content (nglmg protein) in extracts of embryonic and adult chicken liver and intestine. 
TISSUE TYPE STAGE OF DEVELOPMENT (davs) 
10 12 14 16 18 adult 
CG-14 
Liver 182.3+40.00**.a 104.8233.6 102.0+29.2 107220.9 103.4222.3 64.390.9b 
(5) (5) (4) (4) (5) (5) 
Intestine 216.0+86.3-,c 650.82279.5*,C 830.9221 7.5"n,c 11 08.2f31 8.8m,c 1444.3222.5-,c 4651.3f874.1 C 
(5) (5) (5) (6) (6) (6) 
CG-16 
Liver 52.521 4.9- 97.821 4.9- 88.4220.08- 106.8226.2- 93.5213.0" 370.4293.7 
(5) (5) (6) (5) (5) (5) 
Intestine 50.1211.3* 57.621 4.6- 45.3221 .E* 34.5=10.6* 36.8?8.2* 6.61t4.6 
(5) (5) (5) (5) (5) (6) 
*0.05 z p > 0.01, V . 0 1  a p > 0.001, -p S 0.001: significant difference of result for embryonic stages relative to that of the adult organ: a 0.05 z p > 
0.01, b 0.01 a p > 0.01, C p 5 0.001: significant difference of result for CG-14 relative to that for CG-16. Number in brackets denotes the number of 
individual animals for each stage of development. 
91011  12 1314 1516 1718 1920 21 1 adult 1 3 weeks after hatching 
3 days after hatching 
stage of development (days) 
Flg. 2. lmmunoblotting analysis of extract proteins (10 pg per lane) from embryonic, post-hatching and adult chicken liver. A mixture of affinity-purified 
polyclonal immunoglobulin G preparations against CG-14 and CG-16 is used for probing. 
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17181920 21 1 adult 1 3 weeks after hatching 
3 days after hatching 
stage of development (days) 
Fig. 3. lmmunoblotting analysis of extract proteins (10 p g  per lane) from embryonic, post-hatching and adult chicken intestine. A mixture of affinity- 
purified polyclonal immunoglobulin G preparations against CG-14 and CG-16 is used for probing. 
MW (KDa) 
salt extract detergent extract a b Fig. 4. Detection of CG- 
ZUU 
116 
97.4 
stage of development (days) 
extracts of embryonic 
and adult chicken liver. 
Protein aliquots of 
identical quantity (5 pg  
per lane) are separated 
by gel electrophoresis 
under denaturing and 
reductive conditions. 
The proteins are 
electrobloned onto 
nitrocellulose and 
visualized by 
successive incubation 
steps with biotinylated 
CG-16 and signal- 
generating reagents. 
The effect of the 
presence of 0.3M 
lactose and 0.25 mglml 
asialofetuin to block 
carbohydrate- 
dependent binding is 
documented for extracts 
from adult chicken liver 
(lane a). Staining of 
proteins by the 
streptavidinlalkaline 
and chromogenic 
substances in the 
absence of the 
biotinylated lectin is shown for an aliquot of this specimen (lane b). The blot is calibrated with colored standard molecular weight markers. 
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Table 2. Determination of the content of lectin-binding glycoproteins in salt and detergent extracts of embryonic and adult chicken liver and intestine, 
expressed as ng model ligand (asialofetuin)/mg protein. 
ORGAN EXTRACT STAGE OF DEVELOPMENT (days) 
10 12 14 16 18 adult 
CG-14 
Liver 
lntestine 
CG-16 
Liver 
lntestine 
VAA 
Liver 
lntestine 
S: salt extract; D:detergent extract'; *0.05 r p > 0.01, -0.01 r p > 0.001, *p r 0.001: significant difference of result for a distinct embryonic stage 
relative to that of the adult organ. 
note of caveat is appropriate. Direct quantitative 
comparisons of results of solid-phase assays are only 
valid if the spatial parameters of probes are identical. 
Presentation of ligands on a surface entails differential 
accessibility to proteins which differ in size and 
arrangement of ligand-binding sites. Therefore, the 
developmental course of ligand expression for an 
individual lectin can only be correlated to that of another 
sugar receptor with caution, taking the size of the 
proteins into account. In this respect, the small size of 
monomeric CG-14 relative to dimeric CG-16 and 
tetrameric mistletoe agglutinin is an important factor to 
be reckoned with. 
When carbohydrate-inhibitable binding to extract 
compounds was quantitated for CG-14, the relation of 
abundance of reactive sites in salt and detergent extracts 
differed for liver and intestine (Table 2). Salt extracts of 
embryonic liver from day 10 to day 18 contained more 
ligands than respective detergent extracts. In most cases, 
the alterations with stage of development were rather 
similar for both fractions obtained by the two different 
solutions for extraction. There was a general tendency 
for increased presence of CG-14-binding sites with 
maturation, which was reflected on the level of the 
receptor for this galectin only in intestine (Tables 1, 2). 
A similar course of increase for ligand presentation was 
seen, when CG-16 was used as marker (Table 2). It is 
remarkable that a clear-cut correlation between galectin 
presence and expression of galectin-reactive 
glycoproteins only existed in both organs, when the 
contents of both galectins were added up. To examine 
whether this enhancement was restricted to distinct 
galectin-binding components of extracts or could be due 
to elevated presentation of galactose-containing glycans, 
a plant agglutinin with selectivity to a- and 8- 
galactosides was similarly assayed. These experiments 
revealed an increase in binding partners at most time 
points for this agglutinin also (Table 2). It is inherent in 
the assay design that the measurement furnishes an 
insight into the quantitative aspect of ligand presentation 
on the surface of the microtiter plate wells. It is not 
possible to infer the characteristics of the glycan- 
carrying proteins under these conditions. To provide 
information on this issue, lectin blotting was performed 
with extract aliquots of samples which were analyzed 
quantitatively. 
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MW (KDa) detergent extract salt extract Fig. 5. Detection of 
CG-14-binding 
glycoproteins from 
extracts of embryonic 
and adult chicken 
intestine. Protein 
aliquots of identical 
quantity (5 pg  per 
lane) are separated 
by gel electro- 
phoresis under 
denaturing and 
reductive conditions. 
The proteins are 
electroblotted onto 
nitrocellulose and 
visualized by 
successive 
incubation steps with 
biotinylated CG-14 
and signal- 
generating reagents. 
The effect of the 
presence of 0.3M 
lactose and 0.25 
mglml asialofetuin to 
block carbohydrate- 
dependent binding is 
documented for 
extracts from adult 
chicken intestine 
(lane a). Staining of 
stage of development (days) proteins by the 
streptavidin/alkaline 
phosphatase 
conjugate and chromogenic substances in the absence of the biotinylated probe is shown for an aliquot of this specimen (lane b). The blot is calibrated 
with colored standard molecular weight markers. 
neutral g)ycollpid gang).wide neutral glymlipid QanQlioJide neutral plymliprd gengliwlde neutral glyeolipid gangliside 
intestine liver intestlrm liver 
Fig. 6. A. Extent of expression of neutral glycolipids and gangliosides with reactivity to CG-14 from extracts of embryonic and adult chicken intestine 
and liver from 4-8 different animals in a solid-phase assay. The given OD-value for each developmental stage is normalized to the response of an 
aliquot of each fraction which is equivalent to 1 mg tissue (wet weight). Statistical significance of differences of the OD-values behveen the embryonic 
stages and the adult organ is indicated by *0.05apa0.01, and *0.01~p~0.001. B. Extent of expression of neutral glycolipids and gangliosides with 
reactivity to CG-16 from extracts of embryonic and adult chicken intestine and liver from 4-8 different animals in a solid-phase assay. The given OD- 
value for each developmental stage is normalized to the response of an aliquot of each fraction which is equivalent to 1 mg tissue (wet weight). 
Statistical significance of differences of the OD-values between the embryonic stages and the adult organ is indicated by *0.05+pz0.01, and 
**0.01apa0.001. Additionally, statistical significance of differences of the OD-values for the two galectins with tissue samples of the same organ and at 
the same developmental stage is indicated by a0.05+pr0.01; and bO.Olzpa0.001. 
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Fig. 7. Localization of mistletoe lectin-specific binding sites with characteristic staining of the plasma membrane of hepatocytes (a), especially the 
membrane regions forming the bile canaliculi (b). Only quantitative changes occur with maximal staining intensity measurable on day 14 post hatching 
(c), which is reduced in the adult organ (d). Omission of the incubation step with the biotinylated lectin (e) and presence of 0.1 M lactose during the 
incubation step with the lectin (1) provide the essential specificity controls. X 320 
At first ,  it was notable that carbohydrate- consideration to preclude erroneous interpretation (Figs. 
independent and kit reagent-dependent binding reactions 4, 5). Primarily quantitative alterations were assessable 
were visible besides the glycoinhibitor-sensitive i n  the course of development. However, a CG-16- 
staining. These side reactions had to be taken into positive band at 70 kDa was present only during the 
Fig. 8. Localization of mistletoe lectin-specific binding sites in stromal cells in the lamina propria of the intestinal mucosa in sections from embryos (day 
5: a) and adult chicken (b), weakly positive cells (possibly lymphocytes) being present within the columnar epithelial lining, of CG-14-specific binding 
sites in stromal cells in the lamina propria in sections from embryos (day 16: c) and adult chicken (d), of CG-14 in intestinal epithelial cells of embryonic 
(day 20; e) and adult chicken (f), and of CG-16 in columnar epithelial cells of the adult intestine, positive cells being present in the stroma of the villi 
(possibly fibroblasts) (g). Preadsorption of the antibody fraction by an excess of purified antigen (CG-16) blocks the reactivity completely (h). a-c, f-h, X 
1,280; d, X 640; e, 320 
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given embryonic stages in extracts of liver (Fig. 4), 
whereas a CG-14-positive band at 42 kDa was only 
detectable in extracts of adult intestine (Fig.  5 ) .  
Interestingly, the staining intensity of a band at 53 kDa 
decreased with maturation (Fig. 5),  although the overall 
ligand abundance progressively increased (Table 2). 
Since not only proteins, but also lipids are carrier 
backbones of glycan chains, the potential of neutral 
glycolipids and gangliosides to serve as galectin ligands 
warranted further study. Again, the inherent limitations 
of the assay are to be considered. 
In accordance with previous observations (Solomon 
et al., 1991), the immobilization of glycolipids with 
short sugar chains to the surface of microtiter plate wells 
reduced their accessibility. Thus, e.g. N-linked glycans 
of asialofetuin were readily bound by the galectins, 
whereas lactosylceramide or ganglioside GMI failed to 
be reactive even at a quantity of 10 p g  glycolipid per 
assay. Similar to the assays with glycoproteins, the 
disparate size of the galectins can further influence the 
actual result, the tetrameric mistletoe lectin only 
producing very weak responses. The measurements with 
the galectins provided an indication for an increased 
level of accessible in vitro ligands at certain embryonic 
stages for both galectins relative to the adult organ (Fig. 
6A,B). Moreover, differential binding preferences 
towards the tested fractions could be inferred, when 
comparing results of determinations with aliquots of 
extracts using CG-14 and CG-16, as indicated by letters 
in Fig. 6A,B. Similar to the quantitative evaluation of 
Developmental regulation of galectins and their ligands 
glycoprotein in vitro ligands (Table 2) reduction in 
content for one galectin would not translate into a 
concomitant decrease of ligands, supporting the notion 
for overlapping ligand populations. In that case, the 
patterns of localization of the individual galectins and of 
galectin-reactive sites in tissue sections are expected to 
display similarities. As a control marker, the mistletoe 
lectin with defined differences in ligand recognition was 
tested. 
Paraffin-embedded sections of the two organs at 
different stages of development were systematically 
monitored for lectin-binding properties. Staining of plant 
agglutinin-specific s i tes  in the liver yielded a 
characteristic binding pattern which only changed in 
intensity during pre- and post-hatching development. 
The plasma membrane of hepatocytes, especially those 
membrane regions forming the bile canaliculi, was 
prominent with peak intensity on day 14 post-hatching 
(Fig. 7a-d). Kit reagents failed to contribute to this 
reaction (Fig. 7e). Lectin binding was abolished in the 
presence of 0.1M lactose (Fig. 79,  as was likewise noted 
in controls for the positivity of stromal cells in the 
lamina propria of the intestinal mucosa, which is 
illustrated in Fig. 8a,b. Additionally, connective tissue 
elements and dispersed lymphocytes in the epithelium 
were positive. Apical staining of the epithelium was 
confined to developmental stages around the time of 
hatching. Intestinal tissue was primarily positive for CG- 
14 under the given conditions. Biotinylated CG-14 
bound to the epithelium at early stages of embryogenesis 
with a marked labeling of the Golgi area. Stromal cells 
of the lamina propria were distinctly reactive (Fig. 8c). 
From day 16 onwards the staining intensity of this 
compartment, which was also positive immunohisto- 
chemically, leveled off. For stromal cells and muscle 
cells of the lamina muscularis mucosae and tunica 
muscularis a tendency for increased staining intensity 
was detectable (Fig. 8d). Intestinal epithelial cells 
reacted immunohistochemically with the antibody 
fractions against both galectins, as illustrated for CG-14 
presence in intestinal epithelial cells (Fig. 8e,f) and for 
CG-16, which was only detectable in small amounts in 
tissue extracts of adult intestine (Fig. 8g). Preadsorption 
of each antibody fraction with purified galectin 
completely abolished the immunoreactivity (Fig. 8h). 
Compared to CG-14 and in line with the determined 
tissue contents staining intensity was generally rather 
weak including the tunica muscularis and the lamina 
muscularis mucosae. 
The changes of ELISA-detectable galectin contents 
in liver were not as pronounced as those seen in intestine 
(Table 1). The course of expression of in vitro ligands 
was comparable in liver (Table 2). The binding patterns 
of the two galectins in liver were nearly indistin- 
guishable with marked labeling of endothelial cells (Fig. 
9a,b). Similar to the plant agglutinin, staining was due to 
carbohydrate-mediated binding (Fig. 9c,d). The extent of 
binding increased during embryonic development from 
day 10 (negative) to day 21 (markedly positive; Fig. 
9e,f). The differences in fine specificity towards 
carbohydrate structures between the plant agglutinin and 
the two galectins, respectively, translated into different 
tissue-binding profiles. When comparing galectins, not 
only their ligand sites were similar in liver. The patterns 
of immunoreactivity for both galectins were comparable 
with positive reactions in endothelium, parenchyma1 
cells and also erythrocytes (Fig. 10a-f). Since extensive 
preadsorptions of the immunoglobulin G preparations 
with the respective galectin failed to abrogate the 
positivity of erythrocytes, this staining cannot reliably be 
considered to be indicative of galectin presence. 
Discussion 
A key to the individual monitoring of related 
proteins is the availability of non-cross-reactive 
antibodies. As similarly reported by independent groups 
(Beyer and Barondes, 1982a; Hirabayashi et al., 1987; 
Levi and Teichberg, 1989; Castagna and Landa, 1994), 
immunoglobulin fractions with target specificity in 
intergalectin analysis could be obtained. Due to the 
presence of more than one galectin in the extracts, which 
could be fractionated by two-step chromatography, 
ELISA measurements with tools devoid of cross- 
reactivity are indispensable for quantitation. 
Hemagglutination assays will inevitably only provide a 
global result for all galectin activities present. In 
addition to presenting a detailed developmental course 
of the expression of the two galectins in intestine and 
liver our results substantiated that CG-14 can be more 
abundantly expressed in chicken liver, as originally 
reported (Beyer and Barondes, 1982a). Remarkably, 
their profiles of immunohistochemical localization were 
nearly indistinguishable in the liver. While an overlap of 
galectin expression, albeit less pronounced than in liver, 
was seen for intestine despite the low level of CG-16 
expression in adult chicken in agreement with previous 
reports (Beyer et al., 1979; Beyer and Barondes, 1982b), 
a veritable preference was notable for CG-14 with 
respect to localization of galectin-reactive sites in 
intestine. Corroborating the results of the two types of 
solid-phase assays, it can be assumed that the size 
difference of the galectins can have an impact on the 
extent of ligand localization. Monomeric proteins will be 
more suitable to gain access. to a binding partner despite 
the presence of spatial impediments compared to dimeric 
Fig. 9. Localization of specific binding sites for CG-14 (a) and CG-16 (b) in endothelial cells of sections of adult liver. Presence of a mixture of 
glycoinhibitors (0.2M lactose and 0.65 mglml asialofetuin) abolishes the binding reaction (c) and omission of the incubation step with a biotinylated 
galectin yields no staining reaction (d). Localization of reactivity for biotinylated CG-14 during development from day 18 (e) to day 21 (0. a-d, X 320; e, f. 
X 640 
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receptors. 
The arrangement of the carbohydrate recognition 
domains on opposite sites of non-covalently linked 
dimers, however, is the prerequisite for a crosslinking 
activity, which is probably indispensable for signal 
elicitation (Villalobo and Gabius, 1998). Participation of 
human galectin-l in growth control of cultured 
neuroblastoma cells is a graphic example of how a cross- 
linking galectin can partake in regulation of proliferation 
(Kopitz et al., 1998). Besides, a ganglioside glycans of 
glycoproteins can serve as ligands. If their synthesis is 
impaired, serious consequences such as early death and 
dysregulation in epithelia1 cells can ensue, detectable in 
experimental models with ablated I31,4-galactosyl- 
transferase activity (Asano et al., 1997; Lu et al., 1997). 
It can thus be presumed that the two galectins will differ 
in their signal-inducing capacity. In line with reduced 
capacity for hemagglutination, CC-14 lacked the 
inhibitory effectiveness of CG-16 on stimulated T cells 
(Schneller et al., 1995). On the other hand, CG-16, 
which is known as a potent cross-linking agent, was 
capable of triggering various cellular responses, i.e. 
promotion of cartilage differentiation in vitro, inhibition 
of lymphocyte proliferation and induction of apoptosis 
(Matsutani and Yamagata, 1982; Schneller et al., 1995; 
Gupta et al., 1996; Rabinovich et al. ,  1997). 
Histochemical scrutiny of early avian embryogenesis 
further supported this notion, CG-16 presence being 
transiently measurable in connection with proliferative 
activity andlor a phase of differentiation (Levi and 
Teichberg, 1989). Since these parameters are reflected in 
morphometric features and derivatives such as structural 
entropy, which can be readily calculated (Kayser and 
Gabius, 1997; Kayser et al., 1997), detailed combined 
studies will be conducive to delineate the actual extent 
of functional correlation. Moreover, bivalency of a lectin 
is a crucial factor for bridging mechanisms, which guide 
e.g. ordered cell migration in discoidin I-expressing 
slime molds (Gabius et al., 1985). CC-16 presence in 
most cells of the epiblast and hypoblast in the region of 
the primitive streak and in migrating cells during 
gastrulation and the inhibition of primitive streak 
formation by antibody or glycosubstances implicated 
this galectin in early organogenesis (Levi and Teichberg, 
1989; Jeeva and Zalik, 1996). As attested by this report, 
later developmental stages were characterized by a 
coordinated expression of the two galectins. The 
inherent complexity of established organ-specific control 
mechanisms for the two galectins is also striking in 
dermis and epidermis, where CG-14 and CG-16 
expression patterns are obviously regulated non- 
uniformly (Akimoto et al., 1995). 
When viewing ligand abundance in  vitro and 
galectin quantity, it is remarkable that the total amount 
of binding sites nearly dovetailed with the sum of 
presence of both galectins. The gradual increases with 
organ maturation intimate a role in structural 
organization of the two compound classes. In 
mammalian development, only data for the course of 
expression of galectin-l-reactive sites are available, 
pointing to an organ-specific pattern (Kaltner et al., 
1997). To obtain a complete picture on mammalian 
glycoconjugate synthesis comprising any galectin- 
reactive populations, the presence of further galectins 
will need to be assessed. To substantiate the concept of 
assumed functional redundancy by various galectins, as 
implied by only very restricted aberrations i n  the 
olfactory bulb in otherwise normally developing mice 
carrying a null mutation in the galectin-l gene (Poirier 
and Robertson, 1993; Colnot et al., 1997; Key and 
Puche, 1997), this line of research employing the array 
of tissue galectins as tools is a promising approach. In  
this setting, the possibility of compensating functionality 
involving upregulation of individual galectins or 
functionally equivalent proteins in the experimental 
models should be considered, alluding to the thoughtful 
discussion on the caveats within interpretation of data 
from experiments with KO mutants (Hynes, 1996). 
Since tight association with in vivo ligands may hamper 
or even preclude purification of certain galectins by 
standard procedures presupposing solubility, these 
factors should not be neglected to avoid a flawed 
conclusion. It is thus pertinent to refer to the recent 
description of a cDNA with a galectin-3-like sequence 
which is upregulated in chondrocyte hypertrophy, raising 
the possibility for a further extension of the avian 
galectin family at least in this cell type (Nurminskaya 
and Linsenmayer, 1996). 
Conceptually, the foregoing discussion about distinct 
binding partners for galactoside-presenting glycan 
chains underscores a salient aspect. Detailed bio- 
chemical analyses with a panel of ligand derivatives 
have indicated that the identity in nominal mono- 
saccharide specificity for galectins and plant agglutinins 
will not necessarily entail an identical fine specificity 
(Lee et al., 1992; Solis et al., 1996; Galanina et al., 
1997). The differences in the binding site architecture 
can extend or even lead to the selection of distinct 
conformers of an oligosaccharide, further separating the 
in vivo ligand profiles of plant and animal lectins 
(Siebert et al., 1996; Gabius, 1998; Gilleron et al., 1998; 
von der Lieth et al., 1998). It is expedient to appreciate 
that the biochemical disparities will automatically 
translate into distinct histochemical results (Gabius et 
al., 1992; Brinck et al., 1995, 1996; Kaltner et al., 1997). 
Under these circumstances, the inevitable limitations of 
the monitoring of glycoconjugate expression with 
exogenous lectins are readily apparent. The employment 
Fig. 10. lmmunohistochemical localization of CG-14 in sections of livers 14 days (a). 12 days (b), and 18 days post hatching (c) and from adult chicken 
(d) with occurrence of distinct staining of the endothelium, and immunohistochernical localization of CG-16 in sections of livers 7 days post hatching (e) 
and from adult chicken (f), yielding a similar pattern relative to that of CG-14 presence. a. c-f, X 320; b, X 640 

Developmental regulation of galectins and their ligands 
of tissue lectins in efforts to delineate functionally 
relevant alterations by monitoring of glycoconjugate 
expression is strongly advocated. 
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